Full Text

Turn on search term navigation

© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objectives

The aim of this study was to investigate the effect of an oral care tablet containing kiwifruit powder on oral bacteria in tongue coating compared with tongue brushing.

Material and methods

Thirty‐two healthy, young adults were enrolled, and a crossover clinical trial was conducted. The volatile sulfur compound (VSC) concentration, Winkel tongue‐coating index (WTCI), and the number of total bacteria in addition to Fusobacterium nucleatum in tongue coating were measured. We instructed subjects to remove tongue coating by tongue brush for Intervention I, to keep the oral care tablet containing kiwifruit powder on the tongue dorsum and to let it dissolve naturally for Intervention II, and three oral care tablets 1 day before the measurement for Intervention III.

Results

There were significant differences in terms of the level of H2S, VSC, and WTCI at Intervention I and all evaluation values at Intervention II. There were significant differences in terms of the level of H2S, VSC, WTCI, the number of total bacteria, and F. nucleatum at Intervention III. The value of WTCI, the number of bacteria, and F. nucleatum decreased significantly after taking the oral care tablets than after tongue brushing. When compared with Interventions I and III, Intervention III showed the effective results; there were significant differences in the number of total bacteria and F. nucleatum between tongue brushing and taking tablets.

Conclusions

These results suggested that the oral care tablet containing kiwifruit powder could be effective in reducing total bacteria and F. nucleatum in tongue coating when compared with tongue brushing.

Details

Title
Effectiveness of an oral care tablet containing kiwifruit powder in reducing oral bacteria in tongue coating: A crossover trial
Author
Matsumura, Yuki 1 ; Hinode, Daisuke 1   VIAFID ORCID Logo  ; Fukui, Makoto 1   VIAFID ORCID Logo  ; Yoshioka, Masami 2 ; Asakuma, Hiroki 3 ; Takii, Hiroshi 3 

 Department of Hygiene and Oral Health Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan 
 Faculty of Health and Welfare, Tokushima Bunri University, Tokushima, Japan 
 Institute of Health Sciences, Ezaki Glico Co., Ltd., Osaka, Japan 
Pages
197-206
Section
ORIGINAL ARTICLES
Publication year
2020
Publication date
Apr 2020
Publisher
John Wiley & Sons, Inc.
e-ISSN
20574347
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2390205482
Copyright
© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.